
Cholecalciferol (Vitamin D3) Nano Shots
Cholecalciferol Oral Solution IP · Orthopaedics, Nutraceuticals, General Wellness
Product Profile
Cholecalciferol (Vitamin D3) is a critical fat-soluble secosteroid essential for systemic calcium metabolism, skeletal integrity, and severe bone disorder management. As a premier WHO-GMP certified pharmaceutical manufacturer in Baddi, Saar Biotech utilizes advanced aqueous nano-emulsification technology to ensure our 60000 IU Nano Shots deliver unparalleled intestinal absorption, maximum bioavailability, and rapid clinical correction of severe vitamin deficiency.
DCGI Approved
Comprehensive documentation and CDSCO support for rapid market entry in India.
Fast Turnaround
30-45 days lead time for new batches with state-of-the-art logistics.
Pan-India Supply & Contract Manufacturing
Description & Therapeutic Class
This liquid formulation belongs to the Syrups and Nutraceuticals segments, functioning as a high-potency Vitamin D supplement.
Cholecalciferol is the raw, un-hydroxylated form of Vitamin D naturally synthesized in the skin following UVB light exposure. Structurally categorized as a secosteroid (closely related to cholesterol and testosterone), it acts as a pro-hormone. In its active state, it regulates calcium and phosphorus concentrations in the blood, dictating the mineralization of the bone matrix.
For pharmaceutical marketing companies, the 60,000 IU “Nano Shot” has entirely disrupted the traditional Vitamin D3 market. Standard tablets and softgels rely on dietary fat for absorption, leading to highly variable clinical results. By converting the fat-soluble vitamin into a water-miscible nano-emulsion, these shots guarantee rapid, reliable absorption. Brands that successfully market nano-shots consistently capture significant prescription share from orthopedists, pediatricians, and general physicians due to this guaranteed clinical bioperformance.
Pan-India Supply & Contract Manufacturing
The Saar Biotech Advantage
Manufacturing a stable, high-potency nano-emulsion is significantly more complex than filling standard syrups. If the emulsion is unstable, the microscopic lipid droplets will coalesce (merge), leading to phase separation, cloudy liquids, and a total loss of the “nano” bioavailability advantage. As a premier Cholecalciferol Nano Shots Manufacturer Baddi, we have perfected this highly technical process.
- Advanced Nano-Emulsification Matrix: Using high-shear, temperature-controlled homogenization, we fracture the Vitamin D3 oil phase into sub-micron droplets and encapsulate them in a water-miscible surfactant shell. This process makes the fat-soluble vitamin behave as if it were water-soluble, ensuring an elegant, clear, or perfectly homogenous translucent liquid.
- Oxidation & UV Protection: Vitamin D3 degrades rapidly when exposed to oxygen and UV light. Our manufacturing process utilizes specialized inert environments, and our packaging strictly utilizes UV-blocking amber glass or pharmaceutical-grade tinted PET to guarantee the 60,000 IU potency remains intact for the full 18-month shelf life.
- Superior Taste-Masking: Raw lipid-based vitamins have an oily, unpleasant mouthfeel. Our nano-encapsulation inherently masks this texture. We pair it with premium flavor profiles (like Butterscotch or Pineapple) to deliver a delicious, shot-like experience that ensures 100% patient compliance.
- High-Speed Mini-Bottle Filling: The 5ml shot format requires extreme precision filling to ensure label claim accuracy. Our facility utilizes automated, zero-tolerance filling lines capable of processing massive commercial volumes rapidly and cleanly.
Pan-India Supply & Contract Manufacturing
Key Indications & Clinical Usage
Manufactured and supplied from our third-party manufacturing facility in Himachal Pradesh, this high-dose formulation is indicated for the following clinical applications:
- Severe Vitamin D Deficiency: Rapid replenishment of serum 25(OH)D levels in clinically deficient patients.
- Osteomalacia & Rickets: Treatment of impaired bone mineralization leading to softened bones in adults (osteomalacia) and skeletal deformities in children (rickets).
- Hypoparathyroidism: Management of low blood calcium levels induced by underactive parathyroid glands.
- Familial Hypophosphatemia & Fanconi Syndrome: Specialized genetic and renal tubular disorders requiring high-dose vitamin D therapy.
- Osteoporosis Adjunct: Used alongside primary calcium therapy to ensure maximum intestinal calcium assimilation in aging populations.
Note: Due to the high potency (60,000 IU), this product is typically administered as a weekly dose, not daily, and requires prescriber oversight.
Pan-India Supply & Contract Manufacturing
Mechanism of Action & Manufacturing Integrity
Clinical Mechanism
Cholecalciferol is pharmacologically inactive by itself. It functions as a pro-hormone and requires a two-step activation process:
- Hepatic Hydroxylation: In the liver, enzymes (CYP2R1 or CYP27A1) convert Cholecalciferol into 25-hydroxycholecalciferol (calcifediol), the major circulating form of the vitamin.
- Renal Hydroxylation: In the kidneys, it undergoes a second hydroxylation by CYP27B1 to become 1,25-dihydroxycholecalciferol (calcitriol)—the biologically active steroid hormone.
Once active, calcitriol binds to the Vitamin D Receptor (VDR), present in virtually every cell in the body. In the intestine, it radically upregulates the absorption of dietary calcium and phosphorus. In the kidneys, it promotes calcium reabsorption. In the bones, it works synergistically with Parathyroid Hormone (PTH) to regulate bone matrix mineralization.
Manufacturing Integrity
- Potency Preservation: The primary threat to Cholecalciferol during manufacturing is oxidative degradation. Our compounding tanks utilize advanced atmospheric controls to minimize oxidative stress on the raw API.
- Emulsion Stability: A poorly formulated nano-emulsion will “crack” over time, reverting to a standard oil-and-water mixture. We utilize precise thermodynamic balancing and proprietary surfactant ratios to ensure the kinetic stability of the nano-droplets, guaranteeing the product performs physically and clinically exactly as designed, from batch release to expiry.
Pan-India Supply & Contract Manufacturing
Pharmacokinetics & Bioavailability
For pharmaceutical marketers, the commercial dominance of the “Nano Shot” relies entirely on its unique pharmacokinetic bioperformance:
- Bypassing Bile Dependency: Standard Vitamin D3 requires the gallbladder to release bile acids to emulsify the fat before the intestine can absorb it. Our Nano Shot is pre-emulsified into sub-micron droplets. It completely bypasses this biological requirement, allowing for direct, immediate absorption into the lymphatic system.
- Accelerated Cmax & Higher AUC: Clinical literature demonstrates that water-miscible nano-emulsions of Vitamin D3 achieve significantly higher Peak Plasma Concentrations (Cmax) and a greater Area Under the Curve (AUC) compared to oil-based softgels.
- Diet-Independent Absorption: Traditional softgels must be taken with the heaviest, highest-fat meal of the day to work properly. Nano Shots are completely diet-independent. They provide guaranteed absorption whether taken on an empty stomach or with a salad, offering unparalleled convenience to the end-user.
- Tissue Distribution: Once absorbed, it is highly bound (50% to 80%) to the Vitamin D-binding protein (DBP) for systemic transport and hepatic activation.
Pan-India Supply & Contract Manufacturing
B2B & Third-Party Manufacturing
Saar Biotech offers specialized Orthopaedics contract manufacturing India services, specifically optimized for high-volume liquid shot production. If you are seeking a reliable partner to scale your Vitamin D3 portfolio, our Baddi facility provides:
- Facility: Segregated, automated liquid manufacturing block featuring specialized homogenization vessels for nano-emulsion compounding.
- Capacity: High-speed twin-head filling lines capable of rapidly executing high volume liquid manufacturer Baddi deployments, scaling from 10,000 units to massive commercial runs.
- Quality Lab: In-house GLP-certified analytical laboratories equipped with Agilent HPLC systems for exact potency verification.
- Turnaround: 30–45 working days for new private-label brand launches; expedited 20–25 working days for established B2B partners on repeat orders.
- Packaging: Pharmaceutical-grade 5ml amber glass or PET mini-bottles, precision pilfer-proof closures, and highly customized 4x5ml display mono-cartons tailored to your brand identity.
- Regulatory: Full Schedule M compliance and meticulous Batch Manufacturing Record (BMR) transparency.
- MOQ: Flexible entry starting at 5,000–10,000 units per SKU to support aggressive market expansion.
Pan-India Supply & Contract Manufacturing
Storage & Handling Guidelines
- Warehousing Conditions: Store sealed cartons in a cool, dry environment strictly below 25°C. Excessive heat can alter the thermodynamic stability of the nano-emulsion.
- Freeze Protection is Mandatory: The aqueous base must not be exposed to sub-zero temperatures. Freezing will fracture the emulsion matrix, causing irreversible phase separation.
- Light Protection: Direct UV exposure degrades the Cholecalciferol molecule. The primary packaging (amber glass/tinted PET) provides essential protection, and the product should be kept in its outer carton until administration.
- Administration: The 5ml shot is ready-to-drink. It can be consumed directly from the bottle or mixed with a small amount of water or milk, depending on patient preference.
Pan-India Supply & Contract Manufacturing
Quality Control & Compliance Assurance
As a leading Vitamin D3 oral solution manufacturer India, every commercial batch is quarantined until it passes a rigorous, data-driven analytical battery:
- HPLC Assay (Label Claim Accuracy): Quantitative high-performance liquid chromatography confirms the exact Cholecalciferol concentration meets the 60,000 IU IP label claim, ensuring your brand delivers safe, precise high-dose therapy.
- Emulsion Stability Testing: We subject retain samples to accelerated thermal cycling to guarantee the nano-droplets will not coalesce or phase-separate during the product’s lifespan.
- pH & Viscosity Mapping: Tested to confirm the liquid vehicle remains within the optimal range for both chemical stability and patient palatability.
- Microbial Limit Test (MLT): IP-mandated microbiological testing confirming the complete absence of specified pathogens.
- Certificate of Analysis (COA): A comprehensive, parameter-complete COA is issued alongside every B2B batch dispatch, ensuring your brand is perpetually audit-ready.
Pan-India Supply & Contract Manufacturing
Side Effects & Safety Profile
While Vitamin D3 is generally well-tolerated, the 60,000 IU therapeutic dose requires clear safety labeling to prevent hypervitaminosis:
- Adverse Effects: Excessive dosing can lead to hypercalcemia. Symptoms of toxicity include vomiting, constipation, unexpected weight loss, excessive thirst, increased urination, bone pain, and in severe cases, arrhythmias or seizures.
- Allergic Reactions: Very rarely, patients may experience hypersensitivity resulting in swelling of the face, lips, or tongue.
- Contraindications: Strictly contraindicated in patients with hypercalcemia, existing hypervitaminosis D, severe renal impairment, nephrocalcinosis, nephrolithiasis (kidney stones), and high blood phosphate levels. Use with extreme caution in patients with arteriosclerosis or sarcoidosis.
- Healthcare professionals must refer to the complete prescribing information and monitor serum calcium levels during extended therapeutic regimens.
For high-volume contract manufacturing agreements, third-party supply arrangements, or to request complete technical dossiers and pricing for Cholecalciferol (Vitamin D3) 60000 IU Nano Shots, please use the B2B enquiry form below.
Pan-India Supply & Contract Manufacturing
Clinical Q&A for Cholecalciferol (Vitamin D3) Nano Shots
Technical data on bioavailability, pediatric dosing protocols, and therapeutic efficacy for healthcare professionals.
What are the primary indications for Cholecalciferol 60000 IU Nano Shots?
Why is a 'Nano Shot' clinically superior to a standard Vitamin D3 capsule or tablet?
What is the standard dosing protocol for this 60000 IU formulation?
What are the primary contraindications for this high-dose vitamin therapy?
Can this formulation be used safely during pregnancy and lactation?
B2B Manufacturing Guide for Cholecalciferol (Vitamin D3) Nano Shots
Detailed insights on MOQs, lead times, and regulatory support for contractmanufacturing partners.
